Adonis Hijaz, MD
Urology · Cleveland, OHNPI 1992739528
Payments from drug & device makers
Across 405 payments — averaging $649.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bluewind Medical$169K
- Sumitomo Pharma America, Inc.$54K
- Urovant Sciences Inc$21K
- Astellas Pharma US Inc$10K
- Axonics, Inc.$3K
- Medtronic$2K
- plus $4K from 35 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$263,141 in reported general payments places this provider in the 95th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Cleveland
- Howard GoldmanCleveland$747K
- Jihad KaoukCleveland$696K
- Raymond RackleyCleveland$695K
- Sandip VasavadaCleveland$512K
- Petar BajicCleveland$321K
- Sriharan SivalingamCleveland$282K
- Ruben OlivaresCleveland$184K
- Ahmed AboumohamedCleveland$139K
- Jorge Gutierrez AcevesCleveland$90K
- Samuel HaywoodCleveland$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.